XERIS PHARMACEUTICALS INC Contracts & Agreements

Second Supplemental Indenture, by and among the Registrant, Xeris Biopharma Holdings, Inc. and U.S. Bank National Association, dated October 5, 2021 (Filed With SEC on October 5, 2021)

Joinder and Sixth Amendment to Amended and Restated Loan and Security Agreement, dated October 5, 2021, by and among the Registrant, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on October 5, 2021)

Amendment 2 to the Commercial Supply Agreement, dated as of May 13, 2021, by and between Pyramid Laboratories Inc. and the Registrant (Filed With SEC on August 5, 2021)

Amendment 1 to the Quality Agreement, dated as of May 11, 2021, by and between Pyramid Laboratories Inc. and the Registrant (Filed With SEC on August 5, 2021)

Amendment 4 to the Quality Assurance Agreement, dated as of May 5, 2021, by and between Bachem AG and the Registrant (Filed With SEC on August 5, 2021)

Fifth Amendment to Amended and Restated Loan and Security Agreement (Filed With SEC on August 5, 2021)

Separation Agreement, dated as of July 28, 2021, by and between the Company and Barry Deutsch (Filed With SEC on July 29, 2021)

Employment Agreement, dated as of July 28, 2021, by and between the Company and Steven Pieper (Filed With SEC on July 29, 2021)

First Amendment to API Supply Agreement (Filed With SEC on May 13, 2021)

Form of Securities Purchase Agreement (Filed With SEC on March 11, 2021)

Fourth Amendment to Amended and Restated Loan and Security Agreement, dated as of October 23, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on March 9, 2021)

Amended and Restated Quality Agreement, dated as of November 16, 2020, by and between Pyramid Laboratories Inc. and the Registrant (Filed With SEC on March 9, 2021)

Form of Exchange Agreement (Filed With SEC on November 16, 2020)

Amendment to Employment Agreement, by and between the Registrant and John Shannon, dated as of August 18, 2020 (Filed With SEC on November 9, 2020)

Third Amendment to Amended and Restated Loan and Security Agreement, dated as of August 5, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on November 9, 2020)

Second Amendment to Amended and Restated Loan and Security Agreement, dated as of June 30, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Company (Filed With SEC on August 10, 2020)

First Amendment to the Product Supply Agreement, dated as of June 24, 2020, by and between the Company and SHL Pharma LLC (Filed With SEC on August 10, 2020)

Base Indenture, dated as of June 30, 2020, by and between Xeris Pharmaceuticals, Inc. and U.S. Bank National Association (Filed With SEC on July 1, 2020)

Amendment 3 to the Quality Assurance Agreement, dated as of February 26, 2020, by and between the Company and Bachem AG (Filed With SEC on May 7, 2020)

First Amendment to Amended and Restated Loan and Security Agreement, dated April 21, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Company (Filed With SEC on May 7, 2020)

U.S. Small Business Administration Paycheck Protection Program Note, entered into April 21, 2020 by the Company (Filed With SEC on April 24, 2020)

Xeris Pharmaceuticals, Inc. Deferred Compensation Plan (Filed With SEC on April 10, 2020)

Description of Registrant's Securities (Filed With SEC on March 12, 2020)

Underwriting Agreement, dated February 11, 2020, by and among Xeris Pharmaceuticals, Inc., Jefferies LLC and Piper Sandler & Co (Filed With SEC on February 13, 2020)

Amended and Restated Loan and Security Agreement, dated as of September 10, 2019, by and between Oxford Finance LLC, Silicon Valley Bank and Xeris Pharmaceuticals, Inc (Filed With SEC on September 10, 2019)

Second Amendment to Loan and Security Agreement, dated as of May 15, 2019, by and among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on August 6, 2019)

Consulting Agreement between the Registrant and Jonathan Rigby, dated March 26, 2019 (Filed With SEC on May 9, 2019)

Form of Underwriting Agreement (Filed With SEC on February 11, 2019)

Employment Agreement, by and between the Registrant and Beth Hecht (Filed With SEC on February 11, 2019)

First Amendment to Employment Agreement, by and between the Registrant and Beth Hecht (Filed With SEC on February 11, 2019)

First Amendment to Office Lease Agreement, dated as of November 20, 2018, by and between 180 N LaSalle Property Owner LLC and the Registrant (Filed With SEC on February 11, 2019)

Product Supply Agreement by and between SHL Pharma, LLC and the Registrant, dated August 1, 2018 (Filed With SEC on November 8, 2018)

Commercial Supply Agreement, dated as of May 14, 2018, by and between Pyramid Laboratories Inc. and the Registrant (Filed With SEC on June 14, 2018)

Form of Underwriting Agreement (Filed With SEC on June 11, 2018)

Form of Specimen Common Stock Certificate (Filed With SEC on June 11, 2018)

2018 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on June 11, 2018)

Form of Amended and Restated Employment Agreement, by and between the Registrant and Paul Edick (to be entered into in connection with this offering) (Filed With SEC on June 11, 2018)

Form of Amended and Restated Employment Agreement, by and between the Registrant and John Shannon (to be entered into in connection with this offering) (Filed With SEC on June 11, 2018)

Form of Amended and Restated Employment Agreement, by and between the Registrant and Steven Prestrelski (to be entered into in connection with this offering) (Filed With SEC on June 11, 2018)

Form of Amended and Restated Employment Agreement, by and between the Registrant and Ken Johnson (to be entered into in connection with this offering) (Filed With SEC on June 11, 2018)

Form of Employment Agreement, by and between the Registrant and Barry Deutsch (to be entered into in connection with this offering) (Filed With SEC on June 11, 2018)

2018 Employee Stock Purchase Plan (Filed With SEC on June 11, 2018)

Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated December 31, 2015 (Filed With SEC on May 24, 2018)

2011 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on May 24, 2018)

Senior Executive Cash Incentive Bonus Plan (Filed With SEC on May 24, 2018)

Form of Director Indemnification Agreement (Filed With SEC on May 24, 2018)

Form of Officer Indemnification Agreement (Filed With SEC on May 24, 2018)

Lease Agreement, dated as of September 29, 2017, by and between Are-SD Region No. 30, LLC and the Registrant (Filed With SEC on May 24, 2018)

API Supply Agreement, dated as of January 1, 2018, by and between the Registrant and Bachem Americas, Inc (Filed With SEC on May 24, 2018)

Quality Assurance Agreement, dated as of November 20, 2015, by and between Bachem AG and the Registrant, as amended by (i) Amendment 1 to the Quality Assurance Agreement, dated as... (Filed With SEC on May 24, 2018)

Commercial Supply Agreement, dated as of May 14, 2018, by and between Pyramid Laboratories Inc. and the Registrant (Filed With SEC on May 24, 2018)

Joint Development Agreement, dated as of January 29, 2016, by and between the Registrant and Scandinavian Health Limited (Filed With SEC on May 24, 2018)

Loan and Security Agreement, dated as of February 28, 2018, by and between Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on May 24, 2018)

Quality Agreement, dated as of November 16, 2016, by and between Pyramid Laboratories Inc. and the Registrant (Filed With SEC on May 24, 2018)

Category

Industry

Companies

Contracts

XERIS PHARMACEUTICALS INC Contracts & Agreements